1. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome information [Internet] Cheongju: Korea Centers for Disease Control and Prevention. 2015;cited 2015 June 12. Available from:
http://www.mers.go.kr/mers/html/jsp/main.jsp
3. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI, Swerdlow DL, Watson JT, Madani TA. 2014 MERS-CoV outbreak in Jeddah: a link to health care facilities. N Engl J Med 2015;372:846-854.
4. Hinds W. Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd ed. New York: Wiley; 1999.
6. La Rosa G, Fratini M, Della Libera S, Iaconelli M, Muscillo M. Viral infections acquired indoors through airborne, droplet or contact transmission. Ann Ist Super Sanita 2013;49:124-132.
8. Byers R, Medley SR, Dickens ML, Hofacre KC, Samsonow MA, van Hoek ML. Transfer and reaerosolization of biological contaminant following field technician servicing of an aerosol sampler. J Bioterror Biodef 2013;S3:011.
11. Hui DS, Chow BK, Chu LC, Ng SS, Hall SD, Gin T, Chan MT. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009;135:648-654.
12. Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air 2006;16:335-347.
14. Chao CY, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoshevski D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009;40:122-133.
15. Korea Centers for Disease Control and Prevention. Guideline for management of MERS. 2nd ed. Cheongju: Korea Centers for Disease Control and Prevention; 2014.
20. Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, Hagan P, Hii JL, Ndhlovu PD, Quinnell RJ, Watts CH, Chandiwana SK, Anderson RM. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A 1997;94:338-342.
23. Centers for Disease Control and Prevention (CDC). Severe acute respiratory syndrome: Singapore, 2003. MMWR Morb Mortal Wkly Rep 2003;52:405-411.
26. Le DH, Bloom SA, Nguyen QH, Maloney SA, Le QM, Leitmeyer KC, Bach HA, Reynolds MG, Montgomery JM, Comer JA, Horby PW, Plant AJ. Lack of SARS transmission among public hospital workers, Vietnam. Emerg Infect Dis 2004;10:265-268.
27. Eichenwald HF, Kotsevalov O, Fasso LA. The "cloud baby": an example of bacterial-viral interaction. Am J Dis Child 1960;100:161-173.
28. Bassetti S, Bassetti-Wyss B, D'Agostino R, Gwaltney JM, Pfaller MA, Sherertz RJ. 'Cloud adults' exist: airborne dispersal of Staphylococcus aureus associated with a rhinovirus infection Infectious Diseases Society of America. 38th Annual Meeting of the Infectious Diseases Society of America. 2000 Sep 7-10. New Orleans, LA, USA: Arlington: Infectious Diseases Society of America. 2000.
29. Bassetti S, Bischoff WE, Walter M, Bassetti-Wyss BA, Mason L, Reboussin BA, D'Agostino RB Jr, Gwaltney JM Jr, Pfaller MA, Sherertz RJ. Dispersal of Staphylococcus aureus into the air associated with a rhinovirus infection. Infect Control Hosp Epidemiol 2005;26:196-203.
30. Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, Thomas R, Gwaltney JM Jr. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996;124:539-547.
33. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance bias, and transmissibility. Lancet Infect Dis 2014;14:50-56.
34. Li Y, Yu IT, Xu P, Lee JH, Wong TW, Ooi PL, Sleigh AC. Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am J Epidemiol 2004;160:719-728.
36. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13:752-761.
39. Harriman K, Brosseau L, Trivedi K. Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013;369:1761.
40. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV) [Internet] Atlanta: Centers for Disease Control and Prevention. 2015;cited 2015 June 12. Available from:
http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html
41. Centers for Disease Control and Prevention. Implementing home care and isolation or quarantine of people not requiring hospitalization for MERS-CoV [Internet] Atlanta: Centers for Disease Control and Prevention. 2015;cited 2015 June 12. Available from:
http://www.cdc.gov/coronavirus/mers/hcp/home-care.html
42. MERS: the latest threat to global health security. Lancet 2015;385:2324.
43. World Health Organization Western Pacific Region. WHO Korean MERS joint mission: high level messages [Internet] Manila: World Health Organization Western Pacific Region. 2015;cited 2015 June 12. Available from:
http://www.wpro.who.int/mediacentre/mers-hlmsg/en/